Macrophages derived from septic mice modulate nitric oxide synthase and angiogenic mediators in the heart

Journal of Cellular Physiology

Volumn 228, Issue 7, 2013, Pages 1584-1593

  de la Torre, Eulalia ^a   Hovsepian, Eugenia ^b   Penas, Federico N ^b   Dmytrenko, Ganna ^a   Castro, María E ^a   Goren, Nora B ^b   Sales, Maria E ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; AUTACOID; BACTERIUM LIPOPOLYSACCHARIDE; CD31 ANTIGEN; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ASSAY; CELL FUNCTION; CELL ISOLATION; CELL LYSATE; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; HEART MUSCLE CELL; HOMOGENATE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; IN VIVO STUDY; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SUPERNATANT; TISSUE CULTURE; UPREGULATION; ZYMOGRAPHY;

ANIMALS; FEMALE; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MYOCARDIUM; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE; SEPSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

BACTERIA (MICROORGANISMS); MUS;

EID: 84875537438     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24320     Document Type: Article

References (37)

1. Allavena P, Sica A, Garlanda C, Mantovani A. 2008. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222: 155-161.
2. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
3. Carmeliet P. 2005. Angiogenesis in life, health and medicine. Nature 438: 932-936.
4. Cohen J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
5. Colasanti M, Persichini T, Cavallieri E, Fabrizi C, Mariotto S, Menegazzi M, Lauro GM, Suzuli H. 1999. Rapid inactivation of NOS-I by lipopolisaccharide plus interferon-gamma-induced tyrosine phosphorilation. J Biol Chem 274: 9915-9917.
6. Connelly L, Palacios-Callender M, Ameixa C, Moncada S, Hobbs AJ. 2001. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol 166: 3873-3881.
7. Connelly L, Jacobs AT, Palacios-Callender M, Moncada S, Hobbs AJ. 2003. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem 278: 26480-26487.
8. Cuenca J, Martín-Sanz P, Alvarez-Barrientos AM, Boscá L, Goren N. 2006. Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis. Am J Pathol 169: 1567-1576.
9. Cursiefen C, Chen L, Borges LP, Jackson D, Cao J, Radziejewski C, D'Amore PA, Dana MR, Wiegand SJ, Streilein JW. 2004. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113: 1040-1050.
10. Davel LE, Jasnis MA, de la Torre E, Gotoh T, Diament M, Sacerdote de Lustig E, Sales ME. 2002. Arginine metabolic pathways involved in the modulation of tumor induced angiogenesis by macrophages. FEBS Let 532: 216-220.
11. de la Torre E, Davel L, Jasnis MA, Gotoh T, Sacerdote de Lustig E, Sales ME. 2005. Muscarinic receptors participation in angiogenic response induced by macrophages from mammary adenocarcinoma-bearing mice. Breast Cancer Res 7: R345-R352.
12. Faveeuw C, Preece G, Ager A. 2001. Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 98: 688-695.
13. Ferrara N, Gerber HP, LeCouter J. 2003. The biology of VEGF and its receptors. Nature Med 9: 669-676.
14. Gijbels KSM, Carton H, Opdenakker G. 1992. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41: 29-34.
15. Goetzl EJ, Banda MJ, Leppert D. 1996. Matrix metalloproteinases in immunity. J Immunol 156: 1-4.
16. 15N) in biological fluids. Anal Biochem 126: 131-138.
17. Hovsepian E, Mirkin GA, Penas F, Manzano A, Bartrons R, Goren NB. 2011. Modulation of inflammatory response and parasitism by 15-Deoxy-Δ(12, 14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. Int J Parasitol 41: 553-562.
18. Kim CO, Huh AJ, Kim MS, Chin BS, Han SH, Choi SH, Jeong SJ, Choi HK, Choi JY, Song YG, Kim JM. 2008. LPS-induced vascular endothelial growth factor expression in rat lung pericytes. Shock 30: 92-97.
19. Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL. 1995. T cell gelatinases mediate basement membrane transmigration in vitro. J Immunol 154: 4379-4389.
20. Lorier G, Touriño C, Kalil RAK. 2011. Coronary angiogenesis as an endogenous response to myocardial ischemia in adults. Arq Bras Cardiol 97: e140-e148.
21. Malik N, Greenfield BW, Wahl AF, Kiener PA. 1996. Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol 156: 3952-3960.
22. Mantovani A, Sica A, Locati M. 2007. New vistas on macrophage differentiation and activation. Eur J Immunol 37: 14-16.
23. Marcet-Palacios M, Graham K, Cass C, Befus AD, Mayers I, Radomski MW. 2003. Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle. J Pharmacol Exp Ther 307: 429-436.
24. Martinez FO, Helming L, Gordon S. 2009. Alternative activation of macrophages: An immunologic functional perspective. Annu Rev Immunol 27: 451-483.
25. Moncada S, Higgs EA. 2006. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147: 193-201.
26. Morrison DC, Ryan JL. 1987. Endotoxins and disease mechanisms. Annu Rev Med 38: 417-432.
27. Nucera S, Biziato D, de Palma M. 2011. The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int J Dev Biol 55: 495-503.
28. Paemen L, Jansen PM, Proost P, Van DJ, Opdenakker G, Hack E, Taylor FB. 1997. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine 9: 412-415.
29. Pagenstecher A, Stalder AK, Kincaid CL, Volk B, Campbell IL. 2000. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. Am J Pathol 157: 197-210.
30. Parks WC, Wilson CL, Lopez-Boado YS. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 4: 617-629.
31. Penas F, Mirkin GA, Hovsepian E, Cevey A, Caccuri R, Sales ME, Goren NB. 2013. PPARγ ligand treatment inhibits cardiac inflammatory mediators induced by infection with different lethality strains of Trypanosoma cruzi. Biochim Biophys Acta 1832: 239-248.
32. Reel B, Sala-Newby GB, Huang WC, Newby AC. 2011. Diverse patterns of cyclooxygenase-independent metalloproteinase gene regulation in human monocytes. Br J Pharmacol 163: 1679-1690.
33. Ren Y, Xie Y, Jiang G, Fan J, Yeung J, Li W, Tam PK, Savill J. 2008. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J Immunol 180: 4978-4985.
34. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65.
35. Takaishi H, Kimura T, Dalal S, Okada Y, D'Armiento J. 2008. Joint diseases and metalloproteinases: A role for MMP-13. Curr Pharm Bioteccnol 9: 47-54.
36. Valledor AF, Comalada M, Santamaría-Babi LF, Lloberas J, Celada A. 2010. Macrophage proinflammatory activation and deactivation: A question of balance. Adv Immunol 108: 1-20.
37. Wells CA, Ravasi T, Faulkner GJ, Carninci P, Okazaki Y, Hayashizaki Y, Sweet M, Wainwright BJ, Hume DA. 2003. Genetic control of the innate immune response. BMC Immunol 4: 5-23.